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Supplementary information 1-Hotspot somatic mutation of the leucine zipper of LUZP2
The leucine zipper protein 2 (LUZP2) has been reported to be deleted in some patients with WAGR syndrome, a genetic disorder with predisposition towards Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation 1, 2 . The SKCM dataset contains in total 34 non-silent somatic mutations of LUZP2 affecting 25 unique residues (9% patient mutation frequency, p-value 2.29e-09, qvalue 2.75e-06). The leucine zipper region of LUZP2 harbors the recurring mutation p.R165C. There are 10 additional mutation sites close to the leucine zipper region between residues 140 and 213. Mutation of the recurring site R165 is observed as well in COAD, where p.R165H is mutated. The mutation of LUZP2 is mutually exclusive to other cancer genes like NRAS, TMEM216, OXA1L, and LCE1B. The 
Supplementary information 3-Mutual exclusivity of driver mutations in TMEM216 in melanoma
The TCGA SKCM study confirmed a dominance of somatic mutations in BRAF of 50% of patients. In 29% of the patients NRAS is mutated in a mutually exclusive setting to BRAF. The NRAS gene was mutated in 86 cases (85 missense, 1 splice-site mutation) which is contributed to 31% all melanoma cases. The genomic observation of strong mutual exclusivity is consistent with NRAS mutations activating both effector cascades BRAF-MEK-ERK and PI3K-Akt 7, 8 . Examination of pattern information of somatic mutations in gene networks provides important information on gene interactions and disease drivers.
The assessment of the mutational pattern in SKCM patients showed strong mutual exclusivity of TMEM216 with other significantly mutated genes. 
